Evidence map›Paper›PMID 33082446›Full record

ArticleScientific reports2020

Synthesis of an acyl-acyl carrier protein synthetase inhibitor to study fatty acid recycling.

Madeline F Currie, Dylan M Persaud, Niralee K Rana, Amanda J Platt, Joris Beld, Kara L Jaremko

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. A broad inhibitor of acyl-acyl carrier protein synthetases.Biochemistry and biophysics reports · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Madeline F CurrieDepartment of Chemistry, Hofstra University, Hempstead, NY, 11549, USA.
Dylan M PersaudDepartment of Chemistry, Hofstra University, Hempstead, NY, 11549, USA.
Niralee K RanaDepartment of Chemistry, Hofstra University, Hempstead, NY, 11549, USA.
Amanda J PlattDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
Joris BeldDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, 19102, USA. jb3669@drexel.edu.
Kara L JaremkoDepartment of Chemistry, Hofstra University, Hempstead, NY, 11549, USA. Kara.L.Jaremko@hofstra.edu.
Hofstra University · USDrexel University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acids are essential to most organisms and are made endogenously by the fatty acid synthase (FAS). FAS is an attractive target for antibiotics and many inhibitors are in clinical development. However, some gram-negative bacteria harbor an enzyme known as the acyl-acyl carrier protein synthetase (AasS), which allows them to scavenge fatty acids from the environment and shuttle them into FAS and ultimately lipids. The ability of AasS to recycle fatty acids may help pathogenic gram-negative bacteria circumvent FAS inhibition. We therefore set out to design and synthesize an inhibitor of AasS and test its effectiveness on an AasS enzyme from Vibrio harveyi, the most well studied AasS to date, and from Vibrio cholerae, a pathogenic model. The inhibitor C10-AMS [5'-O-(N-decanylsulfamoyl)adenosine], which mimics the tightly bound acyl-AMP reaction intermediate, was able to effectively inhibit AasS catalytic activity in vitro. Additionally, C10-AMS stopped the ability of Vibrio cholerae to recycle fatty acids from media and survive when its endogenous FAS was inhibited with cerulenin. C10-AMS can be used to study fatty acid recycling in other bacteria as more AasS enzymes continue to be annotated and provides a platform for potential antibiotic development.

Indexed as

AdenosineAnti-Bacterial AgentsCarbon-Sulfur LigasesCatalysisCholeraDrug DevelopmentFatty AcidsFatty Acid SynthasesHumansSubstrate SpecificityVibrioVibrio choleraeAdenosineAnti-Bacterial AgentsCarbon-Sulfur LigasesFatty AcidsFatty Acid Synthaseslong-chain-fatty-acid-(acyl-carrier-protein) ligase

Identifiers

PMID33082446
PMCPMC7575536
OpenAlexW3093834542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.